Farewell from Carole Renouf, CEO of Melanoma Institute Australia

Farewell from Carole Renouf, CEO of Melanoma Institute Australia

26 March 2018

I am retiring after just over two years in the role of CEO at MIA to join my only child overseas. The move was not foreseen at this time but it is just too hard to be a whole world away.

It is a great privilege to have an organisation placed in your care and to be responsible not only for its safekeeping but also for its enhancement and growth. I use the word ‘care’ deliberately because I think it’s fair to say that is something that has marked my style as a leader – I do care and I take the business of caring for an organisation and its staff, customers and stakeholders extremely seriously (many sleepless nights).

I really hope, as I wrap up over the month of April, that each of you can say you have experienced in some way my quality of care. ‘Quality of care’ are words you may more readily associate with our incredible MIA clinicians, nurses and clinical trials team – in other words, those who are patient-facing – but I would like to think that you might also consider those words in relation to me. I like looking after people and organisations.

Not everything has been attended to but a great, great many things have. The physician’s mantra is “Do no harm”. That is a good start also for a CEO. However, my aim is to leave an organisation better than I found it. A key supporter said to me the other day, “Please don’t let things go backwards now”, which tells me that people can see things have gone forwards, significantly and in the right direction – very reassuring!

There are a number of people I would like to thank who have enabled this.

When I started, I had a very clear vision of what MIA could become and what structures, processes, capabilities and resources would be needed to realise this vision. I worked to build a skilful and professional management team who would buy in to the vision and largely be responsible for bringing it to life. I am confident that this team will not let things go backwards and I will remain forever in their debt for walking so faithfully by my side.

I would like to thank our Board of Directors for also buying into the vision and supporting us to make it happen. Please rest assured the Board has the search for a new CEO well underway. I also thank the Conjoint Medical Directors for working collaboratively with me in a shared leadership model, not an easy task for anyone but the right approach for our organisation.

When you are not a clinician, it is a very difficult challenge to gain the respect of such talented people with such high standards. I believe I have been able to do this and I am very grateful for every moment of sparse time MIA clinicians and/or researchers have chosen to dedicate to me and my staff in order to progress change. Time is the most precious commodity they do not have and so the rarest of gifts they can bestow and when they do that for us, it is a sign of great trust.

Melanoma is a poorly-understood cancer in the community and hence, less well-supported than some other cancers. Trust me, I ran the National Breast Cancer Foundation, so I should know! It was therefore very important to me to learn about and understand the experience of people going through melanoma and its impact on their loved ones and friends. Probably the most meaningful aspect of my role has been meeting patients, their carers and those who have lost someone to melanoma. I wish I could have got out around the country and done more of it.

I don’t think anyone can understand, as the saying goes, until you at least try to “walk a mile in their shoes”, so I made it my business to sit in on clinics at the Poche Centre (obviously with both patient and doctor consent). I was pleased and touched to find that not only did people not mind my being there, but at times I could even help – if only by distracting patients as they were waiting!  I have not forgotten any of the patients I sat in with in clinic and I quickly learnt there to what degree melanoma does not discriminate: they were young, old, rich, poor, blue collar, white collar, local, regional, frightened, stoic, and everything in between.

MIA is fortunate in having passionate community fundraisers and volunteers, all motivated by the impact of melanoma on their loved one and in some cases, the loss of that loved one. It has been so helpful to learn from these lay experts in melanoma and where I could, to assuage their pain by engaging them in activity with MIA.

Meeting those who have gone on to become consumer advocates has also been valuable, as it has helped me champion the importance of consumer representation as part of MIA’s governance structure and of consumer input into our research. I have faith that MIA will continue to advance with this: it is best practice and that is what MIA should and does stand for above all else.

My warmest thanks to all who support the Institute in any way – you are an integral part of any success we have. And we had so many of those in 2017, our 60th anniversary year! Our research is going from strength to strength. Now we need to identify why the new drugs don’t work for everybody and how to circumvent this – that’s the next frontier.

My next challenge on a personal level will be to down tools (in terms of paid work, for the first time ever) and improve my sun safety performance when bathed in the abundance of Andalucian sun. Thus far, I have managed to successfully tackle the impenetrable Spanish bureaucracy and win a residency visa against all odds. A friend is convinced I will wind up as an efficiency consultant to the Spanish Government! It will be a new chapter.

Carole Renouf

 

14 Melanoma Marches down, 7 to go!
19 Mar 2018

14 Melanoma Marches down, 7 to go!

It was a massive weekend of Melanoma Marches with six Marches in: Bendigo, Canberra, Manly, Newcastle, Bunbury and Adelaide.

Melanoma March keeps marching
14 Mar 2018

Melanoma March keeps marching

Weekend two hit the ground marching with Melanoma Marches in Wollongong, Townsville, Mandurah and Western Sydney.

Melanoma March kicks off for 2018
08 Mar 2018

Melanoma March kicks off for 2018

Melanoma Institute Australia's annual fundraising initiative is all systems go!

Calls for urgent crackdown on illegal backyard solariums
07 Mar 2018

Calls for urgent crackdown on illegal backyard solariums

The reported proliferation of illegal commercial solariums is costing lives and requires urgent government intervention.

15-year-old melanoma survivor Toby Rayner will lead Mount Gambier's march against melanoma
28 Feb 2018

15-year-old melanoma survivor Toby Rayner will lead Mount Gambier's march against melanoma

15-year-old melanoma survivor Toby Rayner will lead Mount Gambier’s march against melanoma Julie-Ann Sams knows all too well that melanoma doesn’t discriminate. 

Excision margins for melanoma redefined
21 Feb 2018

Excision margins for melanoma redefined

Updated guidelines defining appropriate excision margins have been published thanks to research from MIA. 

A Pawsome Story of Hope
21 Feb 2018

A Pawsome Story of Hope

Joanne and her trusty companion Frankie spend their days spreading a message of hope in hospitals, nursing homes, even prisons. It is a long way from her darkest hour facing palliative care. This is her story of hope.

A new generation of melanoma researchers
15 Feb 2018

A new generation of melanoma researchers

Melanoma impacts more Australian teenagers and young adults than any other cancer. Dr James Wilmott, who has a young family of his own, has devoted his career to determining why these young Australians are susceptible to melanoma, and importantly, how to save them.

Melanoma Masterclass celebrates Australian luminaries who have transformed melanoma treatment worldwide
13 Feb 2018

Melanoma Masterclass celebrates Australian luminaries who have transformed melanoma treatment worldwide

The extraordinary contribution of Australia’s most distinguished melanoma clinicians and researchers is being celebrated today.

Prestigious award in pathology for Professor Scolyer
09 Feb 2018

Prestigious award in pathology for Professor Scolyer

Congratulations to Professor Richard Scolyer who was awarded the William O. Russell/Joanne Vandenberge Hill Award of Excellence in Pathology.

A Day in the Life Of... Serigne Lo
09 Feb 2018

A Day in the Life Of... Serigne Lo

A Day in the Life Of... Serigne Lo, Research and BioStatistics Manager at Melanoma Institute Australia

Jay inspires others to help end melanoma and so can you
07 Feb 2018

Jay inspires others to help end melanoma and so can you

Jay was your typical Aussie bloke – a truck driver, husband, dad and mate to many. Then he got melanoma. His cancer diagnosis turned his life upside down.

A dilemma no mother-to-be should face
31 Jan 2018

A dilemma no mother-to-be should face

Clair faced an impossible choice – risk delivering her baby early, or delay potentially life-saving melanoma treatment

Join little Madi and Bettina in the fight against melanoma
25 Jan 2018

Join little Madi and Bettina in the fight against melanoma

Little Madi misses her Dad. But she is determined to honour his memory and support life-saving melanoma research.

Toyota and country music fans invited to tip their hat to help tackle Australia's national cancer – melanoma
19 Jan 2018

Toyota and country music fans invited to tip their hat to help tackle Australia's national cancer – melanoma

Melanoma Institute Australia has teamed up with the Toyota Country Music Festival 2018 in Tamworth!

Sun Protection: Facts and Controversies
18 Jan 2018

Sun Protection: Facts and Controversies

MIA's dermatologist shares her knowledge with GPs on debunking myths and controversies on sunscreen.

Shannan Ponton joins our March for a cure
17 Jan 2018

Shannan Ponton joins our March for a cure

Shannan Ponton thought he was invincible – he wasn’t. But his melanoma battle ended up saving more than his own life. 

Surprising finding in rare form of melanoma get patients closer to personalised medicine
11 Jan 2018

Surprising finding in rare form of melanoma get patients closer to personalised medicine

Researchers have demonstrated that immunotherapy is highly effective in treating a rare form of melanoma – a result that is surprising due to the nature of the tumour.  

Using new technology to prevent melanoma
14 Dec 2017

Using new technology to prevent melanoma

Innovation is helping to prevent melanoma developing in the first place.

Research review of 2017
12 Dec 2017

Research review of 2017

Research from MIA is changing the way melanoma is managed worldwide and improving patient survival. Here are a few of our key highlights from this year.